Skip to main content

. 1994 Feb;57(2):254–255. doi: 10.1136/jnnp.57.2.254

Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.

H N Magnani, A H Ruys

PMCID: PMC1072470 PMID: 8126524

254

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Sandercock P. A., van den Belt A. G., Lindley R. I., Slattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):17–25. doi: 10.1136/jnnp.56.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
Toulemonde F. Post-operative pulmonary embolism and meta-analysis. Thromb Res. 1992 Jul 15;67(2):275–276. doi: 10.1016/0049-3848(92)90146-2. [DOI] [PubMed] [Google Scholar]
Turpie A. G., Gent M., Côte R., Levine M. N., Ginsberg J. S., Powers P. J., Leclerc J., Geerts W., Jay R., Neemeh J. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med. 1992 Sep 1;117(5):353–357. doi: 10.7326/0003-4819-117-5-353. [DOI] [PubMed] [Google Scholar]
Turpie A. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Magnani H. N., Hull R. D., Gent M. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet. 1987 Mar 7;1(8532):523–526. doi: 10.1016/s0140-6736(87)90173-5. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES